Parents, physicians and the public attempting to make sense of the controversy about antidepressants are torn between unproven claims and counter-claims about the drugs’ benefits and risks.
Coalition letter to Charles Curie, Administrator, SAMHSA
We are, however, very distressed at what appears to us to be a significant discrepancy between your statements and the reality of SAMHSA’s role in implementing the NFC report recommendations, as well as other discrepancies between your statements and SAMHSA’s actions.
FDA is Selling the Brooklyn Bridge
This issue is NOT about trial lawyers, this issue is about the rights and health, and safety of ordinary citizens.
FDA rules aim to speed drug tests and trim costs
The Food and Drug Administration yesterday issued new guidelines that make it easier for scientists working in universities and small companies to test promising therapies in humans without matching the hefty spending of large drug companies.